Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer

Colaboración

Año: 2016

Pompas-Veganzones, N; Sandonis, V; Perez-Lanzac, A; Beltran, M; Beardo, P; Juarez, A; Vazquez, F; Cozar, JM; Alvarez-Ossorio, JL; Sanchez-Carbayo, M

Título: TUMOR BIOLOGY

• Q2